Get access

Rosiglitazone for type 2 diabetes mellitus

  • Protocol
  • Intervention


  • B Richter,

  • E Bandeira-Echtler,

  • K Bergerhoff,

  • C Clar,

  • SH Ebrahim

Dr Bernd Richter, Coordinating Editor 'Metabolic and Endocrine Disorders Cochrane Review Group', Department of Endocrinology, Diabetes and Rheumatology, Universitaetsklinikum Duesseldorf, Moorenstr. 5, Duesseldorf, 40225, GERMANY.


This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of rosiglitazone in the treatment of type 2 diabetes.